Streetbeat News

Earnings

BCLI

Brainstorm Cell (NASDAQ:BCLI) reported Q2 losses of $(0.13) per share, beating the analyst consensus estimate of $(0.15) by 13.33%. This is a 31.58% increase over losses from the same period last year. Cash, cash equivalents, and short-term bank deposits were approximately $0.75 million as of June 30, 2023, compared to $3.0 million as of December 31, 2022.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 11:06 am

TSVT

2seventy bio reported Q2 losses of $(0.83) per share, a 58.91% increase YoY. The company also reported $36.05M in sales, a 167.38% increase YoY.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 11:06 am

SNDL

Sundial Growers Inc. (NASDAQ:SNDL) reported Q2 sales of C$244.51M, a 9.31% increase from C$223.69M in the same period last year. However, the company also reported a net loss of C$29.988M.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 11:06 am

ONCY

Oncolytics Biotech reported Q2 losses of $(0.12) per share, missing the analyst consensus estimate of $(0.09) by 33.33%. This is a 71.43% decrease from the same period last year. The company reported $24.4 million in cash, cash equivalents, and marketable securities as of June 30, 2023, and closed a $15 million public offering on August 8, 2023.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 11:05 am

FTRE

Fortrea Holdings (NASDAQ:FTRE) reported Q2 adjusted earnings of $0.52 per share, a 46.39% decrease from $0.97 per share YoY. Sales were reported at $793.00M, a slight decrease of 0.01% from $793.10M YoY.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 11:05 am

GMDA

Gamida Cell reported Q2 losses of $(0.31) per share, missing the analyst consensus estimate of $(0.18) by 72.22 percent. The company's cash and equivalents at the end of the quarter were $54.075M.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 11:04 am

SWAG

Stran & Co (NASDAQ:SWAG) reported Q2 losses of $(0.05) per share, missing the analyst consensus estimate of $(0.03) by 66.67%. The company also reported quarterly sales of $17.47 million, missing the analyst consensus estimate of $18.59 million by 6.02%.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 11:03 am

MNDY

monday.com has projected its Q3 total revenue to be between $181M-$183M, surpassing the estimated $179.36M. The company also forecasts its FY23 revenue to be between $713M-$717M, higher than the estimated $704.7M.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 11:03 am

HUMA

Humacyte (NASDAQ:HUMA) reported Q2 losses of $(0.22) per share, which met the analyst consensus estimate. This represents a 15.79% increase in losses compared to the same period last year.

Portfolio Pulse from bharat@benzinga.com

August 14, 2023 | 11:03 am

BTAI

BioXcel Therapeutics reported Q2 losses of $(1.83) per share, missing the analyst consensus estimate of $(1.72) by 6.4 percent. This is a 35.56 percent decrease over losses from the same period last year. However, the company beat the sales estimate of $450.00 thousand by reporting $457.00 thousand.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 11:03 am